1Apelqvist, Bakker K,van Houtum WH, et al. International consensus and practical guidelines on the mangement and the prevention of the diabet- ics foot. International Working Group on the Diabetes Foot[ J]. Diabetes Metab Res Rev,2000,16 ( suppl 1 ) : S84 -S92.
5Boyko El, Ahroni JH, Stensel V, et al. A prospective study of risk fac- tors for diabetic foot ulcer. The seattle diabetic foot study[J]. Diabetes Care, 1999, 22 (7) :1036 - 1042.
5Faglia E, Favales F, Quarantiello A, et al. Angiographic evaluation of peripheral arterial occlusive disease and its role as a prognostic determination for major amputation in diabetic subjects with foot ulcers. Diabetes Care, 1998, 21:625-630.
6Pelbesr GE,Lipsky BA, Gibbon GW. The burden of diabetic foot ulcers.Am J Surg, 1998,176(Supp12A):102.
7Hill SL,HoltZlllan GL.The effects of peripheral vascular disease with osteomyelitis in the diabetic foot. Am J Surg,1999, 177:282-286.
8Laing P. The development and complications of diabetic foot ulcers. Am J Surg,1998, 176(supp12A):11-19.
9吴庆华.糖尿病足的外科治疗[J].中西医结合外科杂志,2003,9:406-406.
10Boulton A J. The diabetic foot: a global view[J]. Diabetes Metab Res Rev,2000,16(suppl 1):S2-S5.
9Kang S J, Mintz GS, Park DW, et al.Mechanisms of Instent restenosis after drug eluting stent implantation intravascular ultra-sound analy- sis[J].Circ Cardiovasc Interv, 2011,4(1):9-14.
10Guildford AL,Stewart HJ,Morris C ,et al.Substrate induced pheno- typic switches of human smooth muscle ceils: an in vitro study of in- stent restenosis activation pathways[J]. J R Soc Interface, 2011, 8(55): 641-649.
